Application of steviobioside in preparation of composition for preventing and treating intestinal ischemia-reperfusion injury

The invention relates to the field of biomedical treatment, in particular to application of stevioside in preparation of a composition for preventing and treating intestinal ischemia-reperfusion injury. The invention also relates to an application of a pharmaceutical composition containing a therapeutically effective amount of steviobioside in preparation of drugs for preventing and treating intestinal ischemia-reperfusion injury. The composition obviously improves intestinal tissue injury and liver tissue injury induced by intestinal ischemia reperfusion, inhibits expression of inflammatory factors and improves the survival rate of the inflammatory factors, has the advantages of remarkable effect, safety, no toxicity and no side effect, and has wide application prospects. 本发明涉及生物医疗领域，具体涉及甜菊双糖苷在制备用于防治肠缺血再灌注损伤的组合物中的应用。本发明还涉及含有治疗有效量的甜菊双糖苷的药物组合物在制备用于防治肠缺血再灌注损伤的药物中的应用。该组合物明显改善肠缺血再灌注诱导的肠组织损伤、肝组织损伤以及抑制炎症因子的表达和提高其生存率，效果显著，安全无毒，无副作用，具有广阔的应用前景。